concurrent track: engineering biology
Showcasing engineering and computational strategies, such as synthetic biology, lab-on-chip systems, and AI, to advance stem cell science, tissue and organ models, and therapeutic innovation.
Organized by:
Nika Shakiba, PhD, University of British Columbia, Canada
Matthias P. Lutolf, PhD, Institute of Human Biology, Roche and École Polytechnique Fédérale de Lausanne (EPFL), Switzerland
*Additional invited and abstract-selected speakers to be determined. Session descriptions and titles may change slightly.
tracking cell fate in biological systems
sponsored by: Allen Institute
Pulin Li, PhD, Whitehead Institute for Biomedical Research, MIT, USA
Anna Kicheva, PhD, Institute of Science and Technology Austria, Austria
Mary Menhart, University of Illinois at Chicago, USA
Walter Piszker, Columbia University, USA
Lizhong Liu, PhD, Westlake University, China
Alice Sherrard, PhD, Yale University, USA
-
This session explores how AI, computational modeling, synthetic biology, and live imaging can be used to track and understand the fundamental principles that govern cell fate.
tissue and organoid engineering
sponsored by: Stem Cell Reports
Josef Penninger, MD, Helmholtz Centre for Infection Research, Germany and The University of British Columbia, Canada
Noo Li Jeon, PhD, Seoul National University, Korea
Verena Schwach, PhD, University of Twente, Netherlands
Assa Sherman, The Hebrew University of Jerusalem, Israel
Ian Shum, PhD, RWTH Aachen School of Medicine, Germany
Sara Szadocka, MUDr., PhD, Hannover Medical School, Germany
-
This session explores advances in tissue and organoid engineering, including organ-on-chip, organoid and immuno-engineering approaches.
engineering cell fate in biological systems
sponsored by: Stem Cell Reports
Wendell A. Lim, PhD, University of California San Francisco, USA
Mona Men Yi Siu, The University of British Columbia, Canada
Clarisse Brunet, PhD, Institut Curie, France
Paraish Misra, PhD, McGill University Health Centre, Canada
Serena Francesca Generoso, MD, PhD, New York University, USA
Kate Galloway, PhD, Massachusetts Institute of Technology, USA
-
This session explores genome engineering and synthetic biology approaches to program cell fate, with a focus on engineering novel stem cell systems.
biomanufacturing stem cell therapies
Mark Skylar-Scott, PhD, Stanford University, USA
Morgan Craig, PhD, Sainte-Justine University Hospital Azrieli Research Centre and Université de Montréal, Canada
Hetti Puhm, University of Zürich, Switzerland
Andras Nagy, PhD, FRSC, Mount Sinai Hospital, Canada
Yifei Miao, Institute of Zoology, Chinese Academy of Sciences (CAS), China
Alex Ng, GC Therapeutics, USA
-
This session highlights technological innovations in 3D bioprinting, nanotechnology, automation, and large-scale culture systems for clinical applications.